Research articlePublished 21 May 2019
Rating of the Safety and Effectiveness of Marijuana, THC/CBD, and CBD for Autism Spectrum Disorders: Results of Two National Surveys
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Methods: A national online survey of the safety and efficacy of marijuana, tetrahydrocannabinol (THC)/ cannabidiol (CBD) products and CBD products was conducted for over 100 individuals with autism spectrum disorders (ASD). Results: The study found that all three phytocannabinoid formulations had overall benefits between “moderate” and “good”. The symptoms that participants reported as most frequently improving were similar for the three treatments. The highest degree of improvements were in symptoms related to calming, including improvements in anxiety (58-71% of participants), irritability (46-65%), aggression/agitation (43-58%), falling asleep (30-58%), staying asleep (32-46%), hyperactivity (26-39%), and sensory sensitivity (28-32%). There were some reported improvements in symptoms related to thinking, including improvements in cognition (32-46%) and attention (26-42%). There were some reported improvements in core ASD symptoms, including social interaction (26-42%), language (26-38%), and stimming/perseveration/desire for sameness (22-27%). There were some reported improvements in depression (16-41%), primarily for marijuana and THC/CBD. The overall Adverse Effect scores for all three phytocannabinoid formulations were generally low, ranging from 0.2 (CBD) to 0.7 (marijuana), so averaging between “no adverse effects=0” and “mild adverse effects=1”. Overall, dry mouth, decreased cognition, fatigue/drowsiness, and dizziness/unsteadiness were the most commonly reported adverse effects, and were generally more common for marijuana (7-15%) than for the other two treatments (1-8%). Conclusion: This survey suggests that marijuana, THC/CBD, and CBD products may have a wide range of benefits for people with ASD, with minimal adverse effects for THC/CBD and CBD, and minimal/mild adverse effects for marijuana. More research is needed to confirm these preliminary survey results.
Keywords
Subjects
Mental Health and PsychologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAutism-Open Access
- SubjectMental Health and Psychology
- BylineArticles whose byline prints “James B Adams”
- BylineArticles whose byline prints “Devon M Coleman”
- BylineArticles whose byline prints “David L Cooper”
- BylineArticles whose byline prints “Kenneth A Bock”
